This brief highlights how the Georgia Department of Public Health and the Ohio Department of Health developed robust opioid overdose surveillance systems.
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...
With the pandemic upending social interaction, youth mental health is an increasingly important issue. This episode explores why understanding the intersection of suicide, overdose, and ACEs is critical to helping individuals live happy ...
This conversation was recorded in May 2020, but felt the lessons and takeaways are still very relevant as we are finally starting to emerge from the COVID-19 pandemic. The rates of depression, suicide, and substance use are expected to ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, treatment funding and insurance ...
The Suicide, Overdose, and Adverse Childhood Experiences Prevention Capacity Assessment Tool (SPACECAT) helps local, state, and territorial health agencies better understand their capacity to address suicide, overdose, and adverse ...
This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health leaders play in each.
Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e
Take Back Day is a nationwide event designed by DEA to encourage communities to dispose of and destroy expired, unused, and unwanted prescription drugs. These programs have proliferated at the state and local levels, growing even as the ...
COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 impacts risk factors for suicide, such as ...
This report highlights recommendations for structuring and advancing cross-agency approaches to substance use disorder prevention and treatment.
Strategic federal legislative efforts to stem the U.S. fentanyl crisis.
Interview with Monica Bharel, MD, MPH, commissioner of the Massachusetts Department of Public Health, about how the state is reducing overdose deaths in underserved populations, training medical students on preventing and managing ...
ASTHO Requests $1 Billion in Emergency Supplemental Funding for Opioid Epidemic ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) is requesting that the Administration and Congress provide $1 billion in ...
Maine launched an innovative initiative focused on improving future health outcomes for youth by helping them connect to their communities and reminding them that that they matter.
In May 2021, President Biden released full details of the fiscal year 2022 budget. Overall, the budget request combines President Biden's American Jobs Plan, his American Families Plan, and funding priorities for the Pentagon and ...
ASTHO's mission is to support, equip, and advocate for state and territorial health officials in their work of advancing the public's health and well-being. To that end, here are the 12 most popular resources our members, partners, ...
This brief analyzes the Colorado Department of Public Health and Environment and the Maine Center for Disease Control and Prevention to participation in the Suicide and Opioid Overdose Prevention Public Health Initiative.
This brief outlines key considerations for state health departments to address the increase in overdose-related deaths during the postpartum period.
This brief highlights evidence supporting the use of nonopioid medications and nonpharmacological interventions for pain management and outlines considerations for states looking to expand the use of these nonopioid alternatives.